Literature DB >> 18323849

Targeting melanocortin receptors: an approach to treat weight disorders and sexual dysfunction.

Jarl E S Wikberg1, Felikss Mutulis.   

Abstract

The melanocortin system has multifaceted roles in the control of body weight homeostasis, sexual behaviour and autonomic functions, and so targeting this pathway has immense promise for drug discovery across multiple therapeutic areas. In this Review, we first outline the physiological roles of the melanocortin system, then discuss the potential of targeting melanocortin receptors by using MC3 and MC4 agonists for treating weight disorders and sexual dysfunction, and MC4 antagonists to treat anorectic and cachectic conditions. Given the complexity of the melanocortin system, we also highlight the challenges and opportunities for future drug discovery in this area.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18323849     DOI: 10.1038/nrd2331

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


  42 in total

1.  Central melanocortin signaling regulates cholesterol.

Authors:  Yi-Chun Loraine Tung; Giles S H Yeo
Journal:  Nat Neurosci       Date:  2010-07       Impact factor: 24.884

2.  Morph-specific genetic and environmental variation in innate and acquired immune response in a color polymorphic raptor.

Authors:  Laura Gangoso; Alexandre Roulin; Anne-Lyse Ducrest; Juan Manuel Grande; Jordi Figuerola
Journal:  Oecologia       Date:  2015-04-04       Impact factor: 3.225

Review 3.  New central targets for the treatment of obesity.

Authors:  Bruce J Sargent; Nicholas A Moore
Journal:  Br J Clin Pharmacol       Date:  2009-12       Impact factor: 4.335

Review 4.  Intracellular signaling mechanisms of the melanocortin receptors: current state of the art.

Authors:  Adriana R Rodrigues; Henrique Almeida; Alexandra M Gouveia
Journal:  Cell Mol Life Sci       Date:  2014-12-12       Impact factor: 9.261

Review 5.  Neural control of energy balance: translating circuits to therapies.

Authors:  Laurent Gautron; Joel K Elmquist; Kevin W Williams
Journal:  Cell       Date:  2015-03-26       Impact factor: 41.582

Review 6.  New advances in models and strategies for developing anti-obesity drugs.

Authors:  Gilbert W Kim; Jieru E Lin; Erik S Blomain; Scott A Waldman
Journal:  Expert Opin Drug Discov       Date:  2013-04-29       Impact factor: 6.098

7.  Mrap2: an accessory protein linked to obesity.

Authors:  Tiemin Liu; Joel K Elmquist; Kevin W Williams
Journal:  Cell Metab       Date:  2013-09-03       Impact factor: 27.287

Review 8.  Synaptic changes induced by melanocortin signalling.

Authors:  Vanni Caruso; Malin C Lagerström; Pawel K Olszewski; Robert Fredriksson; Helgi B Schiöth
Journal:  Nat Rev Neurosci       Date:  2014-02       Impact factor: 34.870

9.  Microinjections of alpha-melanocyte stimulating hormone into the nucleus ambiguus of the rat elicit vagally mediated bradycardia.

Authors:  Vineet C Chitravanshi; Suresh Bhatt; Hreday N Sapru
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-03-18       Impact factor: 3.619

10.  Discrete melanocortin-sensitive neuroanatomical pathway linking the ventral premmamillary nucleus to the paraventricular hypothalamus.

Authors:  L Gautron; R M Cravo; J K Elmquist; C F Elias
Journal:  Neuroscience       Date:  2013-02-26       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.